Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study
Rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis are chronic progressive immune-mediated rheumatic diseases (IMRD) that can cause a progressive disability and joint deformation and thus can impact in healthcare resource utilization (HCRU) and costs. The main outcome of the study...
Saved in:
Main Authors: | Nuria Carballo, Enric Garcia-Alzórriz, Olivia Ferrández, María Eugenia Navarrete-Rouco, Xavier Durán-Jordà, Carolina Pérez-García, Jordi Monfort, Francesc Cots, Santiago Grau |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/cf24e1d4db94433b839a4a3136b664f3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
by: Acar M, et al.
Published: (2018) -
SPONTANEOUS IMMUNOGLOBULIN-SYNTHESIZING ACTIVITY OF B LYMPHOCYTES IN INFLAMMATORY RHEUMATIC DISEASES
by: A.T. T. Mamasaidov, et al.
Published: (2014) -
Protocolo abreviado de resonancia magnética en espondiloartritis: más allá de la sacroileítis
by: Schiappacasse F,Giancarlo, et al.
Published: (2015) -
Remodelación ósea en espondiloartritis
by: Bautista-Molano,Wilson, et al.
Published: (2013) -
Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
by: Amel Rezgui, et al.
Published: (2021)